LOGIN  |  REGISTER
Recursion

Agilent Technologies to Participate in 2025 Bank of America Global Healthcare Conference

September 11, 2025 | Last Trade: US$151.25 6.19 4.27

SANTA CLARA, Calif. / Sep 11, 2025 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year’s Bank of America Global Healthcare Conference in London.

The fireside chat will be at 9:50-10:30 a.m. British Summer Time (BST) on Sept. 25 in London. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Astria Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page